YEONGDEUNGPO-GU/SEOUL - SmartMed Technologies of South Korea today announced that Hana Kotaro has joined the firm as Director of Economic Research.

YEONGDEUNGPO-GU/SEOUL - SmartMed Technologies today announced the opening of its expanded state-of-the-art Cellular Analysis Lab at its Biomedical facility in Seoul.

YEONGDEUNGPO-GU/SEOUL - SmartMed Technologies today announced that it is in advanced discussions to team up with an Indian biotech firm for the development for cell and gene therapy.

YEONGDEUNGPO-GU/SEOUL - SmartMed Technologies today said that its scientists used artificial intelligence to detect a form of pancreatic cancer which could respond to immunotherapy.

YEONGDEUNGPO-GU/SEOUL - SmartMed Technologies today announced that it is researching and testing cladribine as a potential treatment for patients who relapse from Multiple Sclerosis.

YEONGDEUNGPO-GU/SEOUL - SmartMed Technologies of Seoul today announced they it will host a conference to highlight the latest research in tumor mutation.

YEONGDEUNGPO-GU/SEOUL - SmartMed Technologies’ analysts have predicted that by year 2025, hydrogen will be valued at US$180 billion.

Yeongdeungpo-gu/SEOUL - SmartMed Technologies of Seoul today announced it is teaming up with a Chinese biotech firm to help develop a vaccine to combat the COVID-19 virus.

Yeongdeungpo-gu/SEOUL - SmartMed Technologies, a provider intelligence in serving the life science, announced that it will invest US$3 million to expand its complex in Seoul.

Yeongdeungpo-gu/SEOUL - SmartMed Technologies of South Korea today announced that Endo Tanaka has joined the firm as Head of Macro Research.

SmartMed Technologies of Seoul today announced that it is launching its new clear scope pro-tech endoscopic tip protector.

Yeongdeungpo-gu/SEOUL - SmartMed Technologies today announced a call for medical institutions to action towards digital health data access, endorsing global electronic health records.